Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
BD (BDX) Gets EUA, CE Mark for New Molecular Diagnostic Test
11:23am, Tuesday, 16'th Feb 2021
BD's (BDX) new test has the capability to detect SARS-CoV-2 and Influenza A+B in a single test.
Becton Dickinson Lauded by Frost & Sullivan for Enhancing Patient Experience with Its BD Intevia™ Autoinjector
05:00am, Tuesday, 16'th Feb 2021
The solution leverages a modular platform technology that allows rapid customization, optimizing time and cost for pharma companies SANTA CLARA, Calif., Feb. 16, 2021 /PRNewswire/ -- Based on its rece
BD to Present at Upcoming Investor Conferences
05:25pm, Friday, 12'th Feb 2021
FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following u
Becton, Dickinson's COVID-19/Influenza Combo Molecular Assay Wins FDA Emergency Use Nod
08:43am, Friday, 12'th Feb 2021
The FDA has granted Emergency Use Authorization (EUA) to Becton Dickinson and Co's (NYSE: BDX) new molecular test for both SARS-CoV-2 and Influenza A+B. The new test has also received a CE mark i
FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administrat
Becton Dickinson plans dual dollar/euro bond offerings to repay debt
06:49am, Wednesday, 10'th Feb 2021
Medical technology company Becton Dickinson and Co. said Wednesday it is planning a dual-tranche bond offering in dollars and euros to raise the funds to repay outstanding debt. In a regulatory filing
Covid-19 testing drives Becton Dickinson Q1 revenue growth
04:18pm, Friday, 05'th Feb 2021
Medical devices company Becton Dickinson beat the top and bottom line in its first-quarter results. Covid-19 testing helped drive its revenue growth to $867 million.
Becton, Dickinson and Company (BDX) CEO Thomas Polen on Q1 2021 Results - Earnings Call Transcript
01:49pm, Thursday, 04'th Feb 2021
Becton, Dickinson and Company (BDX) CEO Thomas Polen on Q1 2021 Results - Earnings Call Transcript
Becton Dickinson (BDX) Earnings Surpass Estimates in Q1
01:36pm, Thursday, 04'th Feb 2021
Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal first quarter.
Becton Dickinson (BDX) Surpasses Q1 Earnings and Revenue Estimates
08:19am, Thursday, 04'th Feb 2021
Becton Dickinson (BDX) delivered earnings and revenue surprises of 44.90% and 0.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
FRANKLIN LAKES, N.J., Feb. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that new clinical data have found robust
Becton Dickinson (BDX) Earnings Expected to Grow: What to Know Ahead of Q1 Release
01:32pm, Thursday, 28'th Jan 2021
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Becton, Dickinson's (BDX) Shares March Higher, Can It Continue?
11:17am, Thursday, 21'st Jan 2021
As of late, it has definitely been a great time to be an investor in Becton, Dickinson and Company (BDX).
Medical Device Aristocrats For A High Class Dividend Portfolio
04:30am, Thursday, 21'st Jan 2021
Healthcare aristocrats benefit from significant medical device contributions. By and large these healthcare aristocrats share favorable quant metrics on Seeking Alpha, albeit with significant variatio
Federal, Private Tie-Ups Boost COVID-19 Testing Volume
11:17am, Tuesday, 19'th Jan 2021
The Department of Health and Human Services (HHS) promises over $22 billion of funding.
